e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Lung cancer: epidemiology, diagnosis, staging
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
D. Ukena, A. Gröschel, T. Graeter, J. Fleckenstein, M. Wagner, C. M. Kirsch, G. W. Sybrecht, D. Hellwig (Homburg, Germany)
Source:
Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Session:
Lung cancer: epidemiology, diagnosis, staging
Session type:
Oral Presentation
Number:
2867
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ukena, A. Gröschel, T. Graeter, J. Fleckenstein, M. Wagner, C. M. Kirsch, G. W. Sybrecht, D. Hellwig (Homburg, Germany). Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET). Eur Respir J 2004; 24: Suppl. 48, 2867
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Imaging of eosinophilic lung disease
Related content which might interest you:
The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008
The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010
The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009
Imaging in lung cancer: positron emission tomography scan
Source: Eur Respir J 2002; 19: 49S-60S
Year: 2002
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Accuracy of positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) in diagnosis of recurrence of lung cancer after curative first-line therapy: visual and semiquantitative PET analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: Eur Respir J 2001; 17: 802-820
Year: 2001
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019
The place of non-invasive techniques (CT - PET - CT)
Source: Annual Congress 2007 - Mediastinal staging for NSCLC
Year: 2007
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001
The use of SPECT in preoperative assessment of patients with lung cancer
Source: Eur Respir J 2004; 24: 258-262
Year: 2004
Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008
Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung cancer – a pilot study
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004
Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002
Rebuttal
Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems?
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept